Literature DB >> 9248696

The insulin signalling system and the IRS proteins.

M F White1.   

Abstract

During the past few years, the insulin signalling system has emerged as a flexible network of interacting proteins. By utilizing the insulin receptor substrate (IRS)-proteins (IRS-1 and IRS-2), the insulin signal can be amplified or attenuated independently of insulin binding and tyrosine kinase activity, providing an extensible mechanism for signal transmission in multiple cellular backgrounds. By employing IRS-proteins to engage various signalling proteins, the insulin receptor avoids the stoichiometric constraints encountered by receptors which directly recruit SH2-proteins to their autophosphorylation sites. Finally, the shared use of IRS-proteins by multiple receptors is likely to reveal important connections between insulin and other hormones and cytokines which were previously unrecognized, or observed but unexplained.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9248696     DOI: 10.1007/s001250051387

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  112 in total

1.  APS, an adapter protein with a PH and SH2 domain, is a substrate for the insulin receptor kinase.

Authors:  Z Ahmed; B J Smith; K Kotani; P Wilden; T S Pillay
Journal:  Biochem J       Date:  1999-08-01       Impact factor: 3.857

2.  Insulin alters heterogeneous nuclear ribonucleoprotein K protein binding to DNA and RNA.

Authors:  J Ostrowski; Y Kawata; D S Schullery; O N Denisenko; Y Higaki; C K Abrass; K Bomsztyk
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-24       Impact factor: 11.205

3.  Insulin resistance in fat cells from obese Zucker rats--evidence for an impaired activation and translocation of protein kinase B and glucose transporter 4.

Authors:  E Carvalho; C Rondinone; U Smith
Journal:  Mol Cell Biochem       Date:  2000-03       Impact factor: 3.396

4.  Intensive insulin therapy in severely burned pediatric patients: a prospective randomized trial.

Authors:  Marc G Jeschke; Gabriela A Kulp; Robert Kraft; Celeste C Finnerty; Ron Mlcak; Jong O Lee; David N Herndon
Journal:  Am J Respir Crit Care Med       Date:  2010-04-15       Impact factor: 21.405

5.  Histone deacetylase inhibitors prevent apoptosis following lethal hemorrhagic shock in rodent kidney cells.

Authors:  Nikolaos Zacharias; Elizabeth A Sailhamer; Yongqing Li; Baoling Liu; Muhammad U Butt; Fahad Shuja; George C Velmahos; Marc de Moya; Hasan B Alam
Journal:  Resuscitation       Date:  2010-10-30       Impact factor: 5.262

6.  Regulation of insulin receptor substrate 1 (IRS-1)/AKT kinase-mediated insulin signaling by O-Linked beta-N-acetylglucosamine in 3T3-L1 adipocytes.

Authors:  Stephen A Whelan; Wagner B Dias; Lakshmanan Thiruneelakantapillai; M Daniel Lane; Gerald W Hart
Journal:  J Biol Chem       Date:  2009-12-17       Impact factor: 5.157

Review 7.  Defect of insulin signal in peripheral tissues: Important role of ceramide.

Authors:  Rima Hage Hassan; Olivier Bourron; Eric Hajduch
Journal:  World J Diabetes       Date:  2014-06-15

8.  Cell-specific effects of insulin receptor substrate-1 deficiency on normal and IGF-I-mediated colon growth.

Authors:  J G Simmons; Y Ling; H Wilkins; C R Fuller; A J D'Ercole; James Fagin; P K Lund
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-09-06       Impact factor: 4.052

9.  Isoform-specific defects of insulin stimulation of Akt/protein kinase B (PKB) in skeletal muscle cells from type 2 diabetic patients.

Authors:  D Cozzone; S Fröjdö; E Disse; C Debard; M Laville; L Pirola; H Vidal
Journal:  Diabetologia       Date:  2008-01-18       Impact factor: 10.122

10.  Role of the insulin-like growth factor I/insulin receptor substrate 1 axis in Rad51 trafficking and DNA repair by homologous recombination.

Authors:  Joanna Trojanek; Thu Ho; Luis Del Valle; Michal Nowicki; Jin Ying Wang; Adam Lassak; Francesca Peruzzi; Kamel Khalili; Tomasz Skorski; Krzysztof Reiss
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.